Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.

Hou H, Lariviere JP, Demidenko E, Gladstone D, Swartz H, Khan N.

Radiother Oncol. 2009 Apr;91(1):126-31. doi: 10.1016/j.radonc.2008.10.015. Epub 2008 Nov 14.

2.

Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry.

Hou H, Abramovic Z, Lariviere JP, Sentjurc M, Swartz H, Khan N.

Radiat Res. 2010 May;173(5):651-8. doi: 10.1667/RR1947.1.

3.

Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.

Hou H, Khan N, O'Hara JA, Grinberg OY, Dunn JF, Abajian MA, Wilmot CM, Makki M, Demidenko E, Lu S, Steffen RP, Swartz HM.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):834-43.

PMID:
15183487
4.

Repeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygen.

Khan N, Mupparaju S, Hou H, Williams BB, Swartz H.

J Neurosci Methods. 2012 Feb 15;204(1):111-7. doi: 10.1016/j.jneumeth.2011.10.026. Epub 2011 Nov 4.

5.

Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas.

Khan N, Mupparaju S, Hekmatyar SK, Hou H, Lariviere JP, Demidenko E, Gladstone DJ, Kauppinen RA, Swartz HM.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1193-200. doi: 10.1016/j.ijrobp.2010.05.045. Epub 2010 Aug 31.

6.

Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy.

Abramovic Z, Hou H, Julijana K, Sentjurc M, Lariviere JP, Swartz HM, Khan N.

Adv Exp Med Biol. 2011;701:75-82. doi: 10.1007/978-1-4419-7756-4_11.

7.

Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.

Hou H, Mupparaju SP, Lariviere JP, Hodge S, Gui J, Swartz HM, Khan N.

Radiat Res. 2013 Mar;179(3):343-51. doi: 10.1667/RR2811.1. Epub 2013 Feb 7.

8.

Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry.

Hou H, Dong R, Lariviere JP, Mupparaju SP, Swartz HM, Khan N.

J Radiat Res. 2011;52(5):568-74. Epub 2011 Jul 29.

10.

Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation.

Khan N, Li H, Hou H, Lariviere JP, Gladstone DJ, Demidenko E, Swartz HM.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):878-85. doi: 10.1016/j.ijrobp.2008.10.025. Epub 2009 Jan 10.

11.

Tissue oxygenation in a murine SCC VII tumor after X-ray irradiation as determined by EPR spectroscopy.

Fujii H, Sakata K, Katsumata Y, Sato R, Kinouchi M, Someya M, Masunaga S, Hareyama M, Swartz HM, Hirata H.

Radiother Oncol. 2008 Mar;86(3):354-60. Epub 2008 Feb 20.

12.

A comparative evaluation of EPR and OxyLite oximetry using a random sampling of pO(2) in a murine tumor.

Vikram DS, Bratasz A, Ahmad R, Kuppusamy P.

Radiat Res. 2007 Sep;168(3):308-15.

13.

Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation.

Goda F, O'Hara JA, Rhodes ES, Liu KJ, Dunn JF, Bacic G, Swartz HM.

Cancer Res. 1995 Jun 1;55(11):2249-52.

14.

In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors.

Mahy P, De Bast M, Gallez B, Gueulette J, Koch CJ, Scalliet P, Grégoire V.

Radiother Oncol. 2003 Apr;67(1):53-61.

PMID:
12758240
15.

Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators.

Hou H, Dong R, Li H, Williams B, Lariviere JP, Hekmatyar SK, Kauppinen RA, Khan N, Swartz H.

J Magn Reson. 2012 Jan;214(1):22-8. doi: 10.1016/j.jmr.2011.09.043. Epub 2011 Oct 1.

16.

Tumor pO₂ as a surrogate marker to identify therapeutic window during metronomic chemotherapy of 9L gliomas.

Mupparaju S, Hou H, Lariviere JP, Swartz HM, Khan N.

Adv Exp Med Biol. 2011;701:107-13. doi: 10.1007/978-1-4419-7756-4_15.

17.

Skeletal muscle and glioma oxygenation by carbogen inhalation in rats: a longitudinal study by EPR oximetry using single-probe implantable oxygen sensors.

Hou H, Khan N, Lariviere J, Hodge S, Chen EY, Jarvis LA, Eastman A, Williams BB, Kuppusamy P, Swartz HM.

Adv Exp Med Biol. 2014;812:97-103. doi: 10.1007/978-1-4939-0620-8_13.

18.

Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.

Mupparaju S, Hou H, Lariviere JP, Swartz H, Jounaidi Y, Khan N.

Oncol Rep. 2011 Jul;26(1):281-6. doi: 10.3892/or.2011.1268. Epub 2011 Apr 15.

19.

Are hypoxic cells critical for the outcome of fractionated radiotherapy in a slow-growing mouse tumor?

Urano M, Nishimura Y, Kuroda M, Reynolds R.

Radiother Oncol. 1998 Aug;48(2):221-8.

PMID:
9783896
20.

Heterogeneity of regional redox status and relation of the redox status to oxygenation in a tumor model, evaluated using electron paramagnetic resonance imaging.

Takeshita K, Kawaguchi K, Fujii-Aikawa K, Ueno M, Okazaki S, Ono M, Krishna MC, Kuppusamy P, Ozawa T, Ikota N.

Cancer Res. 2010 May 15;70(10):4133-40. doi: 10.1158/0008-5472.CAN-09-4369. Epub 2010 May 4.

Supplemental Content

Support Center